adrenogenital syndromes, virilizing or feminizing, whether acquired or due to adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesis female:adrenal pseudohermaphroditism | heterosexual precocious pseudopuberty | male:isosexual precocious pseudopuberty | macrogenitosomia praecox | sexual precocity with adrenal hyperplasia | virilization (female)

Definition: The principal problem in men is erectile dysfunction (difficulty in developing or maintaining an erection suitable for satisfactory intercourse). In women, the principal problem is vaginal dryness or failure of lubrication. | Female sexual arousal disorder Male erectile disorder Psychogenic impotence

Definition: A disorder characterized by deliberate weight loss, induced and sustained by the patient. It occurs most commonly in adolescent girls and young women, but adolescent boys and young men may also be affected, as may children approaching puberty and older women up to the menopause. The disorder is associated with a specific psychopathology whereby a dread of fatness and flabbiness of body contour persists as an intrusive overvalued idea, and the patients impose a low weight threshold on themselves. There is usually undernutrition of varying severity with secondary endocrine and metabolic changes and disturbances of bodily functi ...[+++]on. The symptoms include restricted dietary choice, excessive exercise, induced vomiting and purgation, and use of appetite suppressants and diuretics.

Symptomatic form of muscular dystrophy of Duchenne and Becker in female carrier

Dyspareunia due to non-psychogenic cause in the female

Pain in female pelvis

Battered woman syndrome

Female wearable urinal, single-use

I Women and children #I1 Number of pregnant women attending ANC at least once during the reporting period #I2a Number of health facilities providing ANC services #I2b Number of health facilities providing ANC services that also provide CD4 testing on site, or have a system for collecting and transporting blood samples for CD4 testing for HIV-infected pregnant women #I2c Number of health facilities providing ANC services that also provide HIV testing and counselling for pregnant women #I2d Number of health facilities providing ANC services that offer both HIV testing and antiretroviral drugs for the prevention of mother-to-child transmission on site #I3 Number of health facilities that offer paediatric ART #I4 Percentage of health facilities ...[+++] that provide virological testing services (e.g. PCR) for diagnosis of HIV in infants on site or from dried blood spots (DBS) #I5 Percentage of pregnant women who were tested for HIV and received their results – during pregnancy, during labour and delivery, and during the post-partum period (< 72 hours), including those with previously known HIV status #I6 Percentage of pregnant women attending antenatal care whose male partner was tested for HIV #I7 Percentage of HIV-infected pregnant women assessed for ART eligibility through either clinical staging or CD4 testing #I8 Percentage of HIV-infected pregnant women who received antiretroviral drugs to reduce the risk of mother-to-child transmission (MTCT) #I9 Percentage of infants born to HIV-infected women receiving antiretroviral prophylaxis for prevention of mother-to-child transmission (PMTCT) #I10 Percentage of infants born to HIV-infected women started on cotrimoxazole (CTX) prophylaxis within two months of birth #I11 Percentage of infants born to HIV-infected women receiving a virological test for HIV within two months of birth #I12 Distribution of feeding practices (exclusive breastfeeding, replacement feeding, mixed feeding/other) for infants born to HIV-infected women at ...

Between 2001-2007 researchers used participatory action research and qualitative methodologies to understand the experience of breast cancer treatment and survivorship from the perspective of lower-income women, women of colour, lesbian women, young women, older women, Francophone women, Aboriginal women and rural women.

The most common cancers for females are breast, lung and colorectal cancer, and the incidence rates for these three cancers remained fairly stable for women throughout the last decade, although lung cancer did increase from 42 per 100,000 women in 1996 to 47 per 100,000 in 2006 (data not shown).

Wollin and Elder (2003) conducted face-to-face interviews about mammograms with 13 culturally Deaf women in Australia. Most of the women over the age of 40 had had a mammogram within the previous two years.